Literature DB >> 19910794

Update on rheumatic manifestations of infectious diseases.

Jennifer Becker1, Kevin L Winthrop.   

Abstract

PURPOSE OF REVIEW: As infectious diseases continue to emerge, and as molecular techniques advance, the rheumatic manifestations of infectious diseases are increasingly recognized and better understood. Herein, we review important recent clinical, epidemiologic, and basic science advances within this area of rheumatology. RECENT
FINDINGS: We searched the U.S. National Library of Medicine PubMed database for relevant articles published since 1 January 2008. We identified a number of studies suggesting a potentially greater role for persistent viral and bacterial infections in the development of rheumatoid arthritis or rheumatoid arthritis-like syndromes. These include emerging pathogens like Chikungunya virus, as well as historically important pathogens like measles. New literature furthers the idea that antecedent infections with Chlamydia sp. could be causative in some cases of undifferentiated spondyloarthritis. Other studies document diagnostic methods capable of distinguishing between Hepatitis C virus and auto-immune driven arthritis allowing clinicians to better target therapy.
SUMMARY: Infectious pathogens are increasingly recognized in association with rheumatic disease. Rheumatologists should be aware of this trend as such recognition may alter the diagnosis and management of rheumatic symptoms, as well as trigger new research opportunities to better understand the causes of rheumatic disease.

Entities:  

Mesh:

Year:  2010        PMID: 19910794     DOI: 10.1097/BOR.0b013e328333b9f5

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  10 in total

1.  Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts.

Authors:  Olga N Karpus; Kirstin M Heutinck; Paul J M Wijnker; Paul P Tak; Jörg Hamann
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

Review 2.  Human microbiome, infections, and rheumatic disease.

Authors:  Ana Clara Caminer; Rebecca Haberman; Jose U Scher
Journal:  Clin Rheumatol       Date:  2017-11-03       Impact factor: 3.650

3.  Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.

Authors:  Alexis Ogdie; Wyki Gina Pang; Kimberly A Forde; Bhangle D Samir; Lakeisha Mulugeta; Kyong-Mi Chang; David E Kaplan; Valerianna K Amorosa; Jay R Kostman; Rajender K Reddy; Ralph H Schumacher; Vincent Lo Re
Journal:  BMC Musculoskelet Disord       Date:  2015-04-19       Impact factor: 2.362

4.  Microbial Infection and Rheumatoid Arthritis.

Authors:  Song Li; Yangsheng Yu; Yinshi Yue; Zhixin Zhang; Kaihong Su
Journal:  J Clin Cell Immunol       Date:  2013-12

Review 5.  Epstein-Barr Virus and Systemic Autoimmune Diseases.

Authors:  Gunnar Houen; Nicole Hartwig Trier
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 6.  Microbiome in Rheumatoid Arthritis and Celiac Disease: A Friend or Foe.

Authors:  Kawther Elsouri; Vania Arboleda; Samantha Heiser; Marc M Kesselman; Michelle Demory Beckler
Journal:  Cureus       Date:  2021-06-09

7.  Correction of fertility disorders in patients with cryoglobulinemia.

Authors:  Borys Gerasun; Roman Kopets; Roman Hrytsko; Oleksandr Gerasun
Journal:  Cent European J Urol       Date:  2013-11-18

8.  "Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case-control study".

Authors:  Ngoc J Wasson; Cara D Varley; Pascal Schwab; Rongwei Fu; Kevin L Winthrop
Journal:  BMC Infect Dis       Date:  2013-11-11       Impact factor: 3.090

9. 

Authors:  Marcos Arêas Marques; Fernanda Penza Adami de Sá; Otília Lupi; Patricia Brasil; Arno von Ristow
Journal:  J Vasc Bras       Date:  2017 Jan-Mar

10.  Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches.

Authors:  Anna Onisiforou; George M Spyrou
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.